Table 3

Sample characteristics, assessment methods and key findings of the eligible studies for systematic review: sudden death

StudyNParticipant ageMutation/diagnosisAssessment methodsKey findings
Guideri et al.49 (1999)54 RTT (F) 28 healthy controls (F)Mean ± SD:
RTT 10 ± 5.5 yr
Healthy controls 9.71 ± 4.6 yr
RTT diagnosis confirmed in each patient, alongside clinical stage based on Hagberg and Witt-Engerstrom7112-lead ECG along with spectral component measurements (VLF, LF and HF) and QTc analysesLF/HF ratio was significantly higher in the RTT group across all 4 stages compared with healthy controls
HR variability (R-R interval) was significantly lower in the RTT group compared with healthy controls
Decreased HR variability was suggested to be a risk factor for sudden death in RTT
Guideri et al.75 (2004)32 RTT (F) 30 age-matched healthy controls (F)RTT 4 ± 4.1 yr
Healthy controls 6.8 ± 2.1 yr
Patients recruited from the Department of Child Neurology, University of SienaEchocardiography to examine structural abnormalities and blood flow of the heart ECG and spectral component measurements (VLF, LF and HF) and QTcLF/HF was significantly higher in the RTT group compared with healthy controls (3.8 ± 2.9 v. 1 ± 0.5; p < 0.001)
QTc interval was significantly longer in the RTT group (0.44 ± 0.02) compared to healthy controls (0.40 ± 0.01; p < 0.001)
No difference in echocardiography findings between the RTT group and healthy controls
Guideri et al.52 (2005)22 RTT (10 active treatment; 12 untreated)*Mean ± SD:
Active treatment 6.3 ± 4.3 yr
Untreated 6.3 ± 4.0 yr
RTT diagnosis confirmed by 2 child neuropsychiatristsSpectral waveform 12-lead ECG, along with spectral components (VLF, LF and HF) and QTc analysesExamined the premises that reduced HR variability in RTT causes sudden death and that acetyl-L-carnitine might increase HR variability and have a protective affect on the cardiac system
In the untreated group, total power and LF decreased significantly from baseline values after 6–18 mo; QTcD was elevated
After 6 mo of acetyl-L-carnitine treatment, total power (p = 0.01), VLF (p = 0.01) and LF (p = 0.009) increased significantly compared to basal values
No statistically significant difference (p = 0.6) in R-R interval between the active treatment and untreated groups at baseline or at follow-up
Acetyl-L-carnitine might have a cardioprotective effect on the ANS and might decrease the frequency of sudden cardiac death in patients with RTT
Julu et al.76 (1997)6 RTT (F)
8 controls (F)
RTT 4–11 yr
Controls 4–11 yr
Information not availableNeuroScope alongside measures such as chest plethysmograph and MAP measurementsIn the RTT group, mean ± SEM CVT was 3.6 ± 0.7 units v. 10.5 ± 0.9 units in the control group (p < 0.001)
MAP was 94.6 ± 6.4 mmHg in controls v. 78 ± 4.33 mmHg in patients with RTT Vagal tone was disrupted during hyperventilation
Immaturity of medullary cardiorespiratory neurons contribute to autonomic disturbances that could result in sudden death in people with RTT
Sekul et al.77 (1994)34 RTT
41 controls
RTT 2–22 yr
Controls 2–18 yr
RTT diagnosis confirmed in each patient, alongside clinical stage based on Hagberg and Witt-Engerstrom71 by 1 or more of the investigatorsECG parametersPatients with RTT had longer QTc intervals (p < 0.001) and T-wave abnormalities (p < 0.001) compared to age-matched controls
In patients with RTT with T-wave abnormalities, the frequency tended to increase from Stage II (36%) to Stage III (69%) and Stage IV (70%)
Changes in T-waves and QTc were highlighted as risk factors that might contribute to sudden death patients with RTT
  • ANS = autonomic nervous system; CVT = cardiac vagal tone; ECG = electrocardiogram; HF = high frequency; HR = heart rate; LF = low frequency; MAP = mean arterial pressure; QT = Q and T waves on electrocardiogram; QTc = corrected QT; QTcD = QTc dispersion; R-R = inter-beat interval; RTT = Rett syndrome; SD = standard deviation; SEM = standard error of the mean; VLF = very low frequency.

  • * Ten girls with RTT were randomized to receive active treatment and 12 girls with RTT were age-matched untreated controls.

  • Data from 61 ECGs (12-lead) were obtained from 34 patients with RTT.